Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammatory Topoproteome of Psoriasis under Etanercept Treatment
2008-006227-31Phase 4Completed
- Sponsor
- Medical Faculty Magdeburg
- Start
- Jan 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in psoriasis, sponsored by Medical Faculty Magdeburg. Primary endpoints: PASI-50 response at 12 weeks and PASI-75 response at 12 weeks. Started Jan 2009; status: completed.
02
Drugs
etanercept
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2008-006227-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006227-31.